InvestorsHub Logo
Followers 1
Posts 34
Boards Moderated 0
Alias Born 04/17/2009

Re: None

Thursday, 01/25/2018 9:09:01 PM

Thursday, January 25, 2018 9:09:01 PM

Post# of 586
So I try to follow the clues and go down the rabbit hole to see who Scythian has ties with. So Aphria is the lead investor in $20 mil in financing. APHQF CEO Vic Neufeld and LHSIF CEO are both on the board. They both run very successful companies in the same sector.
“Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities.”

So maybe it’s market cap is a little high but when it comes to smaller cap companies, management is key. It doesn’t seem like the general public has caught wind of this company as it’s otc volume is always below 5000. Worth keeping an eye on to say the least.

Brian